The man credited with finding the “data signals” that Ivermectin can be used to help treat Covid-19 is South African-born Dr Paul Marik, now based in the US.
As the Chief of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School in the US, Marik has more than 30 years’ experience in a number of medical fields, including pharmacology, anesthesiology, and critical care.
He is board certified in Internal Medicine, Critical Care Medicine, Neurocritical Care and Nutrition Science.
Marik was born in Johannesburg and obtained his medical degree from Wits.
He was an Intensive Care Unit (ICU) attending physician at Chris Hani Baragwanath Hospital in Soweto, and during this time he obtained a Master of Medicine Degree, Bachelor of Science Degree in Pharmacology, Diploma in Anesthesia as well as a Diploma in Tropical Medicine and Hygiene.
When he moved to the US he did a Critical Care Fellowship in Canada, and since 1992, has worked in various teaching hospitals across the US.
A respected author, Marik has written more than 400 peer-reviewed journal articles, is the author of four critical care books, and has been cited more than 35 000 times in peer-reviewed publications.
Marik along with pulmonary and critical care specialist Dr. Pierre Kory are currently managing up a non-profit organization called the Front-Line Covid-19 Critical Care Alliance (FLCCC), where together with a group of experts they develop effective treatment protocols to prevent the transmission of Covid-19.
‘We didn’t invent Ivermectin, but we have popularised it’
The group discovered that Ivermectin, an anti-parasitic medicine, has highly potent anti-viral and anti-inflammatory properties against Covid-19.
According to several studies conducted by the FLCCC, the drug has been shown to decrease viral load, prevent transmission of the virus, and reduce mortality in critically ill patients.
Kory said the FLCCC was not the first group to research the use of the drug against Covid-19; it is rather the first group to bring it to the world’s attention.
“Dr. Marik was really the first one to identify the data signals showing the efficacy for Ivermectin. He did that after about five small clinical trials came out and saw that the drug appeared to be working.”
‘No one has listened’
Marik says the organisation put Ivermectin on the map.
“I think if it wasn’t for us shouting and being so vocal, no one would have listened. Obviously, we didn’t invent Ivermectin, but we have popularised it. We’ve seen how devastating this pandemic has been across the entire world, and we know that if people had followed our approach it would have saved tens of thousands of lives, but no one has listened, and it is a tragedy.”
Ivermectin has been met with scepticism and caution in several countries around the world, including South Africa.
However, earlier this week, the SA Health Products Regulatory Authority (Sahpra) announced it would allow the “controlled, compassionate” use of Ivermectin to help treat Covid-19.
“We have a good answer with Ivermectin. It’s not the only answer, but we think it is part of the approach to this disease,” said Marik.